Inactive Instrument

Arcoma AB Share Price Nasdaq Stockholm

Equities

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq Stockholm
- - Intraday chart for Arcoma AB

Financials

Sales 2024 * 183M 17.35M 0 1.36B Sales 2025 * 199M 18.87M 0 1.48B Capitalization 204M 19.37M 0 1.52B
Net income 2024 * 14M 1.33M - 104M Net income 2025 * 16M 1.52M - 119M EV / Sales 2024 * 1.08 x
Net cash position 2024 * 7M 664K 0 52.15M Net cash position 2025 * 19M 1.8M 0 142M EV / Sales 2025 * 0.93 x
P/E ratio 2024 *
15 x
P/E ratio 2025 *
12.8 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 53.16%
More Fundamentals * Assessed data
Managers TitleAgeSince
Director of Finance/CFO 40 31/12/21
Chief Tech/Sci/R&D Officer 53 31/12/93
Members of the board TitleAgeSince
Director/Board Member 57 31/12/21
Director/Board Member 53 28/02/10
Chairman 52 31/12/16
More insiders
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Calendar
More about the company